Prins GS - Search Results

1

Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.

Habermann H, Ray V, Habermann W, Prins GS. Habermann H, et al. Among authors: prins gs. J Urol. 2002 Feb;167(2 Pt 1):655-60. doi: 10.1016/S0022-5347(01)69118-3. J Urol. 2002. PMID: 11792947

2

Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate.

Habermann H, Chang WY, Birch L, Mehta P, Prins GS. Habermann H, et al. Among authors: prins gs. Endocrinology. 2001 Jan;142(1):359-69. doi: 10.1210/endo.142.1.7893. Endocrinology. 2001. PMID: 11145599

3

Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.

Habermann H, Ray V, Habermann W, Prins GS. Habermann H, et al. Among authors: prins gs. J Urol. 2001 Dec;166(6):2267-72. J Urol. 2001. Corrected and republished in: J Urol. 2002 Feb;167(2 Pt 1):655-60. doi: 10.1016/S0022-5347(01)69118-3. PMID: 11696749 Corrected and republished.

4

Influence of neonatal estrogens on rat prostate development.

Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O, Bieberich C. Prins GS, et al. Reprod Fertil Dev. 2001;13(4):241-52. doi: 10.1071/rd00107. Reprod Fertil Dev. 2001. PMID: 11800163

5

Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells.

Derry JJ, Prins GS, Ray V, Tyner AL. Derry JJ, et al. Among authors: prins gs. Oncogene. 2003 Jul 3;22(27):4212-20. doi: 10.1038/sj.onc.1206465. Oncogene. 2003. PMID: 12833144

6

Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model.

Diwadkar-Navsariwala V, Prins GS, Swanson SM, Birch LA, Ray VH, Hedayat S, Lantvit DL, Diamond AM. Diwadkar-Navsariwala V, et al. Among authors: prins gs. Proc Natl Acad Sci U S A. 2006 May 23;103(21):8179-84. doi: 10.1073/pnas.0508218103. Epub 2006 May 11. Proc Natl Acad Sci U S A. 2006. PMID: 16690748 Free PMC article.

7

Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy.

Prins GS, Sklarew RJ, Pertschuk LP. Prins GS, et al. J Urol. 1998 Mar;159(3):641-9. J Urol. 1998. PMID: 9474117

8

Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.

Wang Z, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG, Swanson SM. Wang Z, et al. Among authors: prins gs. Endocrinology. 2005 Dec;146(12):5188-96. doi: 10.1210/en.2005-0607. Epub 2005 Sep 1. Endocrinology. 2005. PMID: 16141391

9

Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat.

Wang Z, Luque RM, Kineman RD, Ray VH, Christov KT, Lantvit DD, Shirai T, Hedayat S, Unterman TG, Bosland MC, Prins GS, Swanson SM. Wang Z, et al. Among authors: prins gs. Endocrinology. 2008 Mar;149(3):1366-76. doi: 10.1210/en.2007-1410. Epub 2007 Dec 13. Endocrinology. 2008. PMID: 18079205 Free PMC article.

10

Quality of cryopreserved testicular sperm in patients with obstructive and nonobstructive azoospermia.

Prins GS, Dolgina R, Studney P, Kaplan B, Ross L, Niederberger C. Prins GS, et al. J Urol. 1999 May;161(5):1504-8. J Urol. 1999. PMID: 10210383 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters